Clinical Trial Update: A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of belumosudil in children with chronic graft-versus-host disease is currently recruiting in the schoolROCK study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Sanofi | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: RECRUITING